CDK4 and breast carcinoma: It has been well established that miR-34a is downregulated in breast cancer and plays a key role in regulating genes involved in the cell cycle, such as cyclin-dependent kinase 4 (CDK4) and CDK6, as well as BCL2, which participates in apoptotic mechanisms.